Cruise companies catch Israeli wave [p. 17]

By AVI KRAWITZ
November 8, 2006 01:45

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Cruise ship operators Holland American Lines and Princess Cruises will set sail on Israeli seas again after a seven-year absence, the Tourism Ministry said Tuesday. The ministry said the companies informed Tourism Minister Isaac Herzog in a letter of their return after the ministry's Director-General Nahum Itzkovich extended an invitation to the two to cruise into Israel again. Their ships last docked in the country in 2000. The first Holland American ship is scheduled to arrive in April and will be followed closely by the first Princess cruise, which the company said is already sold out. Herzog said he expected the decision to strengthen tourism in the country. Some 13,000 tourists arrived in Israel by sea in 2005, according to the Tourism Ministry.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS